The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy: Results With Respect to Intraprocedural Myocardial Contrast Echocardiography
Abstract
Background —Percutaneous transluminal septal myocardial ablation (PTSMA) has been introduced as an alternative procedure for reducing the left ventricular outflow tract gradient (LVOTG) in hypertrophic obstructive cardiomyopathy. We report on the acute and mid-term results in 91 symptomatic patients with respect to intraprocedural myocardial contrast echocardiography (MCE). Methods and Results —PTSMA was intended for 46 women and 45 men (54.1±15.5 years). In 2 patients, the intervention could not be completed. In the first 30 patients the target vessel was determined by probatory balloon occlusion alone and in the remainder by additional intraprocedural MCE. Resting LVOTG was reduced from 73.8±35.4 to 16.6±18.1 and nostextrasystolic LVOTG from 149.3±42.5 to 61.9±43.0 mm Hg ( P <0.0001 each). In 10 (11%) patients, permanent DDD pacemaker implantation was necessary. Two (2%) patients died, 1 from ventricular fibrillation associated with treatment for chronic obstructive pulmonary disease after 9 days and 1 from fulminant pulmonary embolism after 2 days. After 3 months, mean New York Heart Association class was reduced from 2.8±0.6 to 1.1±1.0 ( P <0.0001). The LVOTG remained reduced to 14.6±25.5 mm Hg at rest and 49.1±48.7 mm Hg ( P <0.0001 each). Four patients underwent successful repeat PTSMA. Determination of the target vessel by MCE was associated with a higher rate of acute (92% vs 70%; P <0.01) and mid-term (94% vs 64%; P <0.01) success. Conclusions —PTSMA is a promising nonsurgical technique for reduction of symptoms and LVOTG in hypertrophic obstructive cardiomyopathy. MCE has been shown to be a useful addition to probatory balloon occlusion for target vessel selection. Prospective, long-term observations of larger populations and a comparison with the established forms of therapy are necessary to determine the definitive significance of PTSMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Nishimura, R. A., & Tajik, A. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00144-7 · Cited by 1,251
ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS
Teare, D. (1958) · Heart · doi:10.1136/hrt.20.1.1 · Cited by 1,081
The Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,007
Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
Sigwart, U. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91267-3 · Cited by 800
Hypertrophic Cardiomyopathy: Clinical Spectrum and Treatment
Wigle, E. D., Rakowski, H., Kimball, B. P., & Williams, W. G. (1995) · Circulation · doi:10.1161/01.cir.92.7.1680 · Cited by 778
BRAUNWALD, E., LAMBREW, C. T., ROCKOFF, S. D., ROSS, J., & MORROW, A. G. (1964) · Circulation · doi:10.1161/01.cir.29.5s4.iv-3 · Cited by 758
Fananapazir, L., Epstein, N. D., Curiel, R. V., Panza, J. A., Tripodi, D., & McAreavey, D. (1994) · Circulation · doi:10.1161/01.cir.90.6.2731 · Cited by 381
Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis).
Brock, R. (1957) · PubMed · Cited by 306
Knight, C., Kurbaan, A. S., Seggewiss, H., Henein, M., Gunning, M., Harrington, D., Fassbender, D., Gleichmann, U., & Sigwart, U. (1997) · Circulation · doi:10.1161/01.cir.95.8.2075 · Cited by 300
Self-citationPacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study
Kappenberger, L., Linde, C., Daubert, C., McKenna, W., Meisel, E., Sadoul, N., Chojnowska, L., Guize, L., Gras, D., Jeanrenaud, X., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015435 · Cited by 298
MORROW, A. G., & BROCKENBROUGH, E. C. (1961) · Annals of Surgery · doi:10.1097/00000658-196108000-00003 · Cited by 287
Seggewiß, H., Gleichmann, U., Faber, L., Faßbender, D., Schmidt, H. K., & Strick, S. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00508-1 · Cited by 267
Self-citationExtent of Clinical Improvement After Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy
McCully, R. B., Nishimura, R. A., Tajik, A. J., Schaff, H. V., & Danielson, G. K. (1996) · Circulation · doi:10.1161/01.cir.94.3.467 · Cited by 229
Robbins, R. C., & Stinson, E. B. (1996) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70310-0 · Cited by 219
Transcoronary chemical ablation of ventricular tachycardia.
Brugada, P., de Swart, H., Smeets, J. L. R. M., & Wellens, H. J. J. (1989) · Circulation · doi:10.1161/01.cir.79.3.475 · Cited by 212
Pollick, C., Rakowski, H., & Wigle, E. D. (1984) · Circulation · doi:10.1161/01.cir.69.1.43 · Cited by 185
Nishimura, R. A., Hayes, D. L., Ilstrup, D. M., Holmes, D. R., & Tajik, A. J. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00445-9 · Cited by 173
The Management of Hypertrophic Cardiomyopathy
Seggewiß, H., Gleichmann, U., & Faber, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370516 · Cited by 87
Self-citationFaber, L., Seggewiß, H., Faßbender, D., Strick, S., Bogunovic, N., & Gleichmann, U. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)81515-5 · Cited by 55
Self-citationHina, K., Iwasaki, K., 野上, 邦., Kita, T., 谷口, 堯., Kusachi, S., Moritani, H., & Tsuji, T. (1993) · Clinical Cardiology · doi:10.1002/clc.4960160507 · Cited by 45
Kathetertherapie der hypertrophen obstruktiven Kardiomyopathie
Gleichmann, U., Seggewiß, H., Faber, L., Faßbender, D., Schmidt, H. K., & Strick, S. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1043055 · Cited by 35
Self-citation
Cited by
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., Ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,578
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 994
Metadata
- Authors
- Faber, L., Seggewiss, H., & Gleichmann, U.
- Venue
- Circulation
- Published
- 1998-12
- Volume
- 98
- Issue
- 22
- Pages
- 2415-2421
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2042811509
- Cited by
- 348
- References
- 22
- FWCI
- 10.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.